Survival rate and risk factors for patients with retinoblastoma in Japan. The Committee for the National Registry of Retinoblastoma
- PMID: 1513060
Survival rate and risk factors for patients with retinoblastoma in Japan. The Committee for the National Registry of Retinoblastoma
Abstract
Clinical, pathological and follow-up data on the 1,147 cases of retinoblastoma registered in Japan from 1975 to 1982 were statistically analyzed. The cumulative survival rate of the total 1,147 cases was 93.0% at 5 years and 90.3% at 10 years, calculated by the Kaplan-Meier method. The survival rate for the 757 unilateral cases was 93.3% at 5 years and 92.3% at 10 years. For the 390 bilateral cases, however, the rate was 92.2% at 5 years and 86.7% at 10 years. The Cox multivariate analysis indicated that, among the various clinical and pathological findings in the patients, extraocular invasion by the tumor was the most significant risk factor which is predictive of death due to tumor. The survival rate for patients with extraocular invasion was significantly better in cases undergoing subsequent local radiation and/or systemic chemotherapy than in cases without such aftercare. The cumulative incidence rate of second neoplasms in 409 cases of hereditary retinoblastoma was 4.8% at 10 years, 9.8% at 15 years and 15.7% at 20 years. The occurrence of a second neoplasm was the main cause of death in the hereditary cases 10 years after the first onset.
Similar articles
-
[National registry of retinoblastoma in Japan (1975-1982). The Committee for the National Registry of Retinoblastoma].Nippon Ganka Gakkai Zasshi. 1992 Nov;96(11):1433-42. Nippon Ganka Gakkai Zasshi. 1992. PMID: 1476074 Japanese.
-
Retinoblastoma in Turkey--treatment and prognosis.Jpn J Ophthalmol. 1996;40(1):95-102. Jpn J Ophthalmol. 1996. PMID: 8739506
-
Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.J Natl Cancer Inst. 2008 Dec 17;100(24):1771-9. doi: 10.1093/jnci/djn394. Epub 2008 Dec 9. J Natl Cancer Inst. 2008. PMID: 19066271
-
[Retinoblastoma: clinical and molecular diagnostic aspects].Praxis (Bern 1994). 1996 Aug 27;85(35):1058-62. Praxis (Bern 1994). 1996. PMID: 8848678 Review. French.
-
[Malignant ophthalmic tumors].Nihon Rinsho. 1993 Jan;51 Suppl:1013-20. Nihon Rinsho. 1993. PMID: 8459526 Review. Japanese. No abstract available.
Cited by
-
Retinoblastoma in Taiwan: survival rate and prognostic factors.Jpn J Ophthalmol. 2006 May-Jun;50(3):242-9. doi: 10.1007/s10384-005-0320-y. Jpn J Ophthalmol. 2006. PMID: 16767380
-
Second Primary Malignant Neoplasms in Survivors of Retinoblastoma in a Single Ocular Oncology Practice.Clin Ophthalmol. 2024 Oct 30;18:3103-3109. doi: 10.2147/OPTH.S484968. eCollection 2024. Clin Ophthalmol. 2024. PMID: 39493838 Free PMC article.
-
Orbital retinoblastoma: Present status and future challenges - A review.Saudi J Ophthalmol. 2011 Apr;25(2):159-67. doi: 10.1016/j.sjopt.2010.10.010. Epub 2010 Oct 13. Saudi J Ophthalmol. 2011. PMID: 23960917 Free PMC article.
-
Early onset sebaceous carcinoma.Diagn Pathol. 2011 Sep 5;6:81. doi: 10.1186/1746-1596-6-81. Diagn Pathol. 2011. PMID: 21892948 Free PMC article.
-
Incidence and Characteristics of Retinoblastoma in Poland: The First Nationwide Study 2010-2017.Int J Environ Res Public Health. 2021 Jun 17;18(12):6539. doi: 10.3390/ijerph18126539. Int J Environ Res Public Health. 2021. PMID: 34204493 Free PMC article.
MeSH terms
LinkOut - more resources
Medical